Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD)
Tetsuya Akaishi(Tohoku University Hospital), Kazuo Fujihara(Tohoku University), Ichiro Nakashima(Tohoku Medical and Pharmaceutical University), Toshiyuki Takahashi(Fukushima Medical University), Masashi Aoki(Tohoku University), Michiaki Abe(Tohoku University Hospital), Tadashi Ishii(Tohoku University Hospital)
Cited by 57
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740